{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:48:56Z","timestamp":1768315736664,"version":"3.49.0"},"publisher-location":"Singapore","reference-count":134,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811377082","type":"print"},{"value":"9789811377099","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7709-9_1","type":"book-chapter","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:57:22Z","timestamp":1567537042000},"page":"1-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Production and Purification of Therapeutic Enzymes"],"prefix":"10.1007","author":[{"given":"M. \u00c2ngela","family":"Taipa","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Carla C. C. R.","family":"de Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21691401.2018.1425213","volume":"46","author":"HM Abdel-Mageed","year":"2018","unstructured":"Abdel-Mageed HM, Fahmy AS, Shaker DS, Mohamed SA (2018) Development of novel delivery system for nanoencapsulation of catalase: formulation, characterization, and in vivo evaluation using oxidative skin injury model. Artif Cells Nanomed Biotechnol 46:1\u201310. https:\/\/doi.org\/10.1080\/21691401.2018.1425213","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4018\/978-1-5225-5237-6.ch003","volume-title":"Research advancements in pharmaceutical, nutritional, and industrial enzymology","author":"K Abderrezak","year":"2018","unstructured":"Abderrezak K (2018) Therapeutic enzymes used for the treatment of non-deficiency diseases. In: Shashi Lata B, Pankaj Kumar C (eds) Research advancements in pharmaceutical, nutritional, and industrial enzymology. IGI Global, Hershey, pp 46\u201370. https:\/\/doi.org\/10.4018\/978-1-5225-5237-6.ch003"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.plaphy.2016.06.029","volume":"108","author":"M Abdoli-Nasab","year":"2016","unstructured":"Abdoli-Nasab M, Javaran MJ, Cusido RM, Palazon J (2016) Purification of recombinant tissue plasminogen activator (rtPA) protein from transplastomic tobacco plants. Plant Physiol Biochem 108:139\u2013144. https:\/\/doi.org\/10.1016\/j.plaphy.2016.06.029","journal-title":"Plant Physiol Biochem"},{"issue":"1","key":"1_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/biom4010117","volume":"4","author":"JL Adrio","year":"2014","unstructured":"Adrio JL, Demain AL (2014) Microbial enzymes: tools for biotechnological processes. Biomol Ther 4(1):117\u2013139. https:\/\/doi.org\/10.3390\/biom4010117","journal-title":"Biomol Ther"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nbt1007-1097","volume":"25","author":"S Aggarwal","year":"2007","unstructured":"Aggarwal S (2007) What\u2019s fueling the biotech engine? Nat Biotechnol 25:1097\u20131104. https:\/\/doi.org\/10.1038\/nbt1007-1097","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1_CR6","first-page":"32","volume":"10","author":"V Agrawal","year":"2012","unstructured":"Agrawal V, Bal M (2012) Strategies for rapid production of therapeutic proteins in mammalian cells. Bioprocess Int 10(4):32\u201348","journal-title":"Bioprocess Int"},{"key":"1_CR7","unstructured":"Allied_Market_Research (2018) Specialty enzymes market is expected to reach $947.5 million, globally, by\u00a02020. https:\/\/www.alliedmarketresearch.com\/press-release\/specialty-enzymes.html. Accessed 17 Aug 2018"},{"issue":"2","key":"1_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/imt.10.90","volume":"3","author":"C Andrady","year":"2011","unstructured":"Andrady C, Sharma SK, Chester KA (2011) Antibody\u2013enzyme fusion proteins for cancer therapy. Immunotherapy 3(2):193\u2013211. https:\/\/doi.org\/10.2217\/imt.10.90","journal-title":"Immunotherapy"},{"issue":"1","key":"1_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pep.2005.12.002","volume":"48","author":"J Arnau","year":"2006","unstructured":"Arnau J, Lauritzen C, Petersen GE, Pedersen J (2006) Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. Protein Expr Purif 48(1):1\u201313. https:\/\/doi.org\/10.1016\/j.pep.2005.12.002","journal-title":"Protein Expr Purif"},{"issue":"1","key":"1_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40259-015-0116-7","volume":"29","author":"BA Baldo","year":"2015","unstructured":"Baldo BA (2015) Enzymes approved for human therapy: indications, mechanisms and adverse effects. BioDrugs 29(1):31\u201355. https:\/\/doi.org\/10.1007\/s40259-015-0116-7","journal-title":"BioDrugs"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1385\/1-59259-655-x:455","volume-title":"Protein purification protocols","author":"J Bonnerjea","year":"2004","unstructured":"Bonnerjea J (2004) Purification of therapeutic proteins. In: Cutler P (ed) Protein purification protocols. Humana Press, Totowa, pp 455\u2013462. https:\/\/doi.org\/10.1385\/1-59259-655-x:455"},{"issue":"1","key":"1_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","volume":"57","author":"RO Brady","year":"2006","unstructured":"Brady RO (2006) Enzyme replacement for lysosomal diseases. Annu Rev Med 57(1):283\u2013296. https:\/\/doi.org\/10.1146\/annurev.med.57.110104.115650","journal-title":"Annu Rev Med"},{"issue":"2","key":"1_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0168-1656(91)90228-N","volume":"20","author":"A Brandazza","year":"1991","unstructured":"Brandazza A, Lee E, Ferrera M, Tillman U, Sarmientos P, Westphal H (1991) Use of the urokinase-type plasminogen activator gene as a general tool to monitor expression in transgenic animals: study of the tissue-specificity of the murine whey acidic protein (WAP) expression signals. J Biotechnol 20(2):201\u2013212. https:\/\/doi.org\/10.1016\/0168-1656(91)90228-N","journal-title":"J Biotechnol"},{"issue":"4","key":"1_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0958-1669(02)00330-0","volume":"13","author":"GPL Cereghino","year":"2002","unstructured":"Cereghino GPL, Cereghino JL, Ilgen C, Cregg JM (2002) Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 13(4):329\u2013332. https:\/\/doi.org\/10.1016\/S0958-1669(02)00330-0","journal-title":"Curr Opin Biotechnol"},{"issue":"7","key":"1_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1021\/sb500343g","volume":"4","author":"F Cheng","year":"2015","unstructured":"Cheng F, Kardashliev T, Pitzler C, Shehzad A, Lue H, Bernhagen J, Zhu L, Schwaneberg U (2015a) A competitive flow cytometry screening system for directed evolution of therapeutic enzyme. ACS Synth Biol 4(7):768\u2013775. https:\/\/doi.org\/10.1021\/sb500343g","journal-title":"ACS Synth Biol"},{"issue":"3","key":"1_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00253-014-5985-z","volume":"99","author":"F Cheng","year":"2015","unstructured":"Cheng F, Zhu L, Lue H, Bernhagen J, Schwaneberg U (2015b) Directed arginine deiminase evolution for efficient inhibition of arginine-auxotrophic melanomas. Appl Microbiol Biotechnol 99(3):1237","journal-title":"Appl Microbiol Biotechnol"},{"key":"1_CR150","doi-asserted-by":"crossref","unstructured":"Chon JH, Zarbis-Papastoitsis G (2011) New Biotechnol 28(5):458\u2013463. https:\/\/doi.org\/10.1016\/j.nbt.2011.03.015","DOI":"10.1016\/j.nbt.2011.03.015"},{"issue":"12","key":"1_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tplants.2009.09.009","volume":"14","author":"H Daniell","year":"2009","unstructured":"Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14(12):669\u2013679. https:\/\/doi.org\/10.1016\/j.tplants.2009.09.009","journal-title":"Trends Plant Sci"},{"issue":"7","key":"1_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.4155\/tde-2017-0020","volume":"8","author":"SN Dean","year":"2017","unstructured":"Dean SN, Turner KB, Medintz IL, Walper SA (2017) Targeting and delivery of therapeutic enzymes. Ther Deliv 8(7):577\u2013595. https:\/\/doi.org\/10.4155\/tde-2017-0020","journal-title":"Ther Deliv"},{"issue":"3","key":"1_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biotechadv.2009.01.008","volume":"27","author":"AL Demain","year":"2009","unstructured":"Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27(3):297\u2013306. https:\/\/doi.org\/10.1016\/j.biotechadv.2009.01.008","journal-title":"Biotechnol Adv"},{"issue":"10","key":"1_CR20","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1110\/ps.9.10.2009","volume":"9","author":"C Derst","year":"2000","unstructured":"Derst C, Henseling J, R\u00f6hm KH (2000) Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Sci 9(10):2009\u20132017","journal-title":"Protein Sci"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/B978-0-12-220851-5.00011-3","volume-title":"Bioprocess engineering principles","author":"PM Doran","year":"2013","unstructured":"Doran PM (2013) Chapter 11: Unit operations. In: Doran PM (ed) Bioprocess engineering principles, 2nd edn. Academic, London, pp 445\u2013595. https:\/\/doi.org\/10.1016\/B978-0-12-220851-5.00011-3","edition":"2"},{"issue":"10","key":"1_CR22","doi-asserted-by":"publisher","first-page":"25831","DOI":"10.3390\/ijms161025831","volume":"16","author":"KJ Dozier","year":"2015","unstructured":"Dozier KJ, Distefano DM (2015) Site-specific PEGylation of therapeutic proteins. Int J Mol Sci 16(10):25831\u201325864. https:\/\/doi.org\/10.3390\/ijms161025831","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1_CR23","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1021\/cb500257s","volume":"9","author":"L Fang","year":"2014","unstructured":"Fang L, Chow KM, Hou S, Xue L, Chen X, Rodgers DW, Zheng F, Zhan C-G (2014) Rational design, preparation, and characterization of a therapeutic enzyme mutant with improved stability and function for cocaine detoxification. ACS Chem Biol 9(8):1764\u20131772. https:\/\/doi.org\/10.1021\/cb500257s","journal-title":"ACS Chem Biol"},{"issue":"3","key":"1_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1021\/acs.bioconjchem.7b00719","volume":"29","author":"SA Farhadi","year":"2018","unstructured":"Farhadi SA, Bracho-Sanchez E, Freeman SL, Keselowsky BG, Hudalla GA (2018) Enzymes as immunotherapeutics. Bioconjug Chem 29(3):649\u2013656. https:\/\/doi.org\/10.1021\/acs.bioconjchem.7b00719","journal-title":"Bioconjug Chem"},{"issue":"1","key":"1_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/2193-1801-3-395","volume":"3","author":"R Fazel","year":"2014","unstructured":"Fazel R, Zarei N, Ghaemi N, Namvaran MM, Enayati S, Mirabzadeh Ardakani E, Azizi M, Khalaj V (2014) Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris. Springerplus 3(1):395. https:\/\/doi.org\/10.1186\/2193-1801-3-395","journal-title":"Springerplus"},{"issue":"1","key":"1_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13068-018-1077-0","volume":"11","author":"RG Ferreira","year":"2018","unstructured":"Ferreira RG, Azzoni AR, Freitas S (2018) Techno-economic analysis of the industrial production of a low-cost enzyme using E. coli: the case of recombinant \u03b2-glucosidase. Biotechnol Biofuels 11(1):81. https:\/\/doi.org\/10.1186\/s13068-018-1077-0","journal-title":"Biotechnol Biofuels"},{"issue":"5","key":"1_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.tibtech.2010.02.003","volume":"28","author":"BA Fong","year":"2010","unstructured":"Fong BA, Wu W-Y, Wood DW (2010) The potential role of self-cleaving purification tags in commercial-scale processes. Trends Biotechnol 28(5):272\u2013279. https:\/\/doi.org\/10.1016\/j.tibtech.2010.02.003","journal-title":"Trends Biotechnol"},{"issue":"5","key":"1_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11095-013-1233-y","volume":"31","author":"G Fuhrmann","year":"2014","unstructured":"Fuhrmann G, Leroux J-C (2014) Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives. Pharm Res 31(5):1099\u20131105. https:\/\/doi.org\/10.1007\/s11095-013-1233-y","journal-title":"Pharm Res"},{"issue":"1","key":"1_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/02652048.2015.1115902","volume":"33","author":"MG Funaro","year":"2016","unstructured":"Funaro MG, Nemani KV, Chen Z, Bhujwalla ZM, Griswold KE, Gimi B (2016) Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase. J Microencapsul 33(1):64\u201370. https:\/\/doi.org\/10.3109\/02652048.2015.1115902","journal-title":"J Microencapsul"},{"issue":"5","key":"1_CR30","doi-asserted-by":"publisher","first-page":"e19013","DOI":"10.1371\/journal.pone.0019013","volume":"6","author":"M Giffard","year":"2011","unstructured":"Giffard M, Fert\u00e9 N, Ragot F, El Hajji M, Castro B, Bonnet\u00e9 F (2011) Urate oxidase purification by salting-in crystallization: towards an alternative to chromatography. PLoS One 6(5):e19013. https:\/\/doi.org\/10.1371\/journal.pone.0019013","journal-title":"PLoS One"},{"issue":"2","key":"1_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/microorganisms6020038","volume":"6","author":"AMV Gomes","year":"2018","unstructured":"Gomes AMV, Carmo TS, Carvalho LS, Bahia FM, Parachin NS (2018) Comparison of yeasts as hosts for recombinant protein production. Microorganisms 6(2):38. https:\/\/doi.org\/10.3390\/microorganisms6020038","journal-title":"Microorganisms"},{"issue":"2","key":"1_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1207\/s15327914nc330201","volume":"33","author":"NJ Gonzalez","year":"1999","unstructured":"Gonzalez NJ, Isaacs LL (1999) Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer 33(2):117\u2013124. https:\/\/doi.org\/10.1207\/s15327914nc330201","journal-title":"Nutr Cancer"},{"issue":"6","key":"1_CR33","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s12010-013-0115-4","volume":"169","author":"HG Goojani","year":"2013","unstructured":"Goojani HG, Javaran MJ, Nasiri J, Goojani EG, Alizadeh H (2013) Expression and large-scale production of human tissue plasminogen activator (t-PA) in transgenic tobacco plants using different signal peptides. Appl Biochem Biotechnol 169(6):1940\u20131951. https:\/\/doi.org\/10.1007\/s12010-013-0115-4","journal-title":"Appl Biochem Biotechnol"},{"issue":"6","key":"1_CR34","first-page":"335","volume":"2","author":"CR Goward","year":"1992","unstructured":"Goward CR, Stevens GB, Tattersall R, Atkinson T (1992) Rapid large-scale preparation of recombinant Erwinia chrysanthemi L-asparaginase. Bioseparation 2(6):335\u2013341","journal-title":"Bioseparation"},{"issue":"1","key":"1_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","volume":"122","author":"GA Grabowski","year":"1995","unstructured":"Grabowski GA, Barton NW, Pastores G et al (1995) Enzyme therapy in type 1 gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med 122(1):33\u201339. https:\/\/doi.org\/10.7326\/0003-4819-122-1-199501010-00005","journal-title":"Ann Intern Med"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphar.2017.00419","volume":"8","author":"SK Gupta","year":"2017","unstructured":"Gupta SK, Shukla P (2017) Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: a review. Front Pharmacol 8:419. https:\/\/doi.org\/10.3389\/fphar.2017.00419","journal-title":"Front Pharmacol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"329121","DOI":"10.1155\/2013\/329121","volume":"2013","author":"N Gurung","year":"2013","unstructured":"Gurung N, Ray S, Bose S, Rai V (2013) A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. Biomed Res Int 2013:329121. https:\/\/doi.org\/10.1155\/2013\/329121","journal-title":"Biomed Res Int"},{"issue":"4","key":"1_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.tibtech.2014.02.001","volume":"32","author":"AT Hanke","year":"2014","unstructured":"Hanke AT, Ottens M (2014) Purifying biopharmaceuticals: knowledge-based chromatographic process development. Trends Biotechnol 32(4):210\u2013220. https:\/\/doi.org\/10.1016\/j.tibtech.2014.02.001","journal-title":"Trends Biotechnol"},{"issue":"4","key":"1_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0734-9750(94)90004-3","volume":"12","author":"DR Headon","year":"1994","unstructured":"Headon DR, Walsh G (1994) The industrial production of enzymes. Biotechnol Adv 12(4):635\u2013646. https:\/\/doi.org\/10.1016\/0734-9750(94)90004-3","journal-title":"Biotechnol Adv"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/nbt1027","volume":"22","author":"S Hellwig","year":"2004","unstructured":"Hellwig S, Drossard J, Twyman RM, Fischer R (2004) Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 22:1415\u20131422. https:\/\/doi.org\/10.1038\/nbt1027","journal-title":"Nat Biotechnol"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.plaphy.2017.06.013","volume":"118","author":"D Hidalgo","year":"2017","unstructured":"Hidalgo D, Abdoli-Nasab M, Jalali-Javaran M, Bru-Mart\u00ednez R, Cusid\u00f3 RM, Corchete P, Palazon J (2017) Biotechnological production of recombinant tissue plasminogen activator protein (reteplase) from transplastomic tobacco cell cultures. Plant Physiol Biochem 118:130\u2013137. https:\/\/doi.org\/10.1016\/j.plaphy.2017.06.013","journal-title":"Plant Physiol Biochem"},{"key":"1_CR42","doi-asserted-by":"publisher","unstructured":"Ho SV (1990) Strategies for large-scale protein purification. In: Protein purification. vol 427. ACS symposium series, vol 427. American Chemical Society, pp 14\u201334. https:\/\/doi.org\/10.1021\/bk-1990-0427.ch002","DOI":"10.1021\/bk-1990-0427.ch002"},{"key":"1_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/9783527807796.ch7","volume-title":"Industrial biotechnology","author":"H Hohmann","year":"2016","unstructured":"Hohmann H, van Dijl JM, Krishnappa L, Pr\u00e1gai Z (2016) Host organisms: Bacillus subtilis. In: Wittmann C, Liao JC (eds) Industrial biotechnology, vol 1. Wiley, Weinheim. https:\/\/doi.org\/10.1002\/9783527807796.ch7"},{"issue":"3","key":"1_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10295-011-1082-9","volume":"39","author":"C Huang Jr","year":"2012","unstructured":"Huang C Jr, Lin H, Yang X (2012) Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol 39(3):383\u2013399. https:\/\/doi.org\/10.1007\/s10295-011-1082-9","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"5","key":"1_CR45","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/btpr.436","volume":"26","author":"Y-M Huang","year":"2010","unstructured":"Huang Y-M, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog 26(5):1400\u20131410. https:\/\/doi.org\/10.1002\/btpr.436","journal-title":"Biotechnol Prog"},{"issue":"7","key":"1_CR46","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s12010-013-0450-5","volume":"171","author":"HZ Jaliani","year":"2013","unstructured":"Jaliani HZ, Farajnia S, Mohammadi SA, Barzegar A, Talebi S (2013) Engineering and kinetic stabilization of the therapeutic enzyme Anabeana variabilis phenylalanine ammonia lyase. Appl Biochem Biotechnol 171(7):1805\u20131818. https:\/\/doi.org\/10.1007\/s12010-013-0450-5","journal-title":"Appl Biochem Biotechnol"},{"key":"1_CR47","first-page":"40","volume":"103","author":"KP Jayapal","year":"2007","unstructured":"Jayapal KP, Wlaschin KF, Hu WS, Yap MGS (2007) Recombinant protein therapeutics from CHO cells\u00a0\u2013 20 years and counting. Chem Eng Prog 103:40\u201347","journal-title":"Chem Eng Prog"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pep.2016.06.015","volume":"127","author":"D Jeyaharan","year":"2016","unstructured":"Jeyaharan D, Aston P, Garcia-Perez A, Schouten J, Davis P, Dixon AM (2016) Soluble expression, purification and functional characterisation of carboxypeptidase G2 and its individual domains. Protein Expr Purif 127:44\u201352. https:\/\/doi.org\/10.1016\/j.pep.2016.06.015","journal-title":"Protein Expr Purif"},{"issue":"3","key":"1_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/prep.1994.1035","volume":"5","author":"ED Kakkis","year":"1994","unstructured":"Kakkis ED, Matynia A, Jonas AJ, Neufeld EF (1994) Overexpression of the human lysosomal enzyme \u03b1-L-iduronidase in Chinese hamster ovary cells. Protein Expr Purif 5(3):225\u2013232. https:\/\/doi.org\/10.1006\/prep.1994.1035","journal-title":"Protein Expr Purif"},{"issue":"2","key":"1_CR50","first-page":"29","volume":"3","author":"R Kaur","year":"2012","unstructured":"Kaur R, Sekhon BS (2012) Enzymes as drugs: an overview. J Pharm Educ Res 3(2):29\u201341","journal-title":"J Pharm Educ Res"},{"issue":"1","key":"1_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pep.2004.07.009","volume":"38","author":"A Khushoo","year":"2004","unstructured":"Khushoo A, Pal Y, Singh BN, Mukherjee KJ (2004) Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II. Protein Expr Purif 38(1):29\u201336. https:\/\/doi.org\/10.1016\/j.pep.2004.07.009","journal-title":"Protein Expr Purif"},{"issue":"6","key":"1_CR52","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1742-4658.2009.06910.x","volume":"276","author":"GA Kotzia","year":"2009","unstructured":"Kotzia GA, Labrou NE (2009) Engineering thermal stability of L-asparaginase by in vitro directed evolution. FEBS J 276(6):1750\u20131761. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06910.x","journal-title":"FEBS J"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-981-10-4284-3_2","volume-title":"Bioresources and bioprocess in biotechnology: volume 2 : Exploring potential biomolecules","author":"SS Kumar","year":"2017","unstructured":"Kumar SS, Abdulhameed S (2017) Therapeutic enzymes. In: Sugathan S, Pradeep NS, Abdulhameed S (eds) Bioresources and bioprocess in biotechnology: volume 2 : Exploring potential biomolecules. Springer, Singapore, pp 45\u201373. https:\/\/doi.org\/10.1007\/978-981-10-4284-3_2"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/b978-0-12-805419-2.00015-0","volume-title":"Enzymes in human and animal","author":"A Kunamneni","year":"2018","unstructured":"Kunamneni A, Ogaugwu C, Goli D (2018) Chapter 15: Enzymes as therapeutic agents. In: Nunes C, Kumar V (eds) Enzymes in human and animal. Nutrition Academic Press, Oxford, pp 301\u2013312. https:\/\/doi.org\/10.1016\/b978-0-12-805419-2.00015-0"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","volume":"251","author":"M-E Lalonde","year":"2017","unstructured":"Lalonde M-E, Durocher Y (2017) Therapeutic glycoprotein production in mammalian cells. J Biotechnol 251:128\u2013140. https:\/\/doi.org\/10.1016\/j.jbiotec.2017.04.028","journal-title":"J Biotechnol"},{"key":"1_CR56","unstructured":"Langer ES (2017) Trends and growth in single-use system (SUS) adoption. Am Pharm Rev 343797"},{"issue":"1","key":"1_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/fmb.14.104","volume":"10","author":"B Laukens","year":"2015","unstructured":"Laukens B, Visscher CD, Callewaert N (2015) Engineering yeast for producing human glycoproteins: where are we now? Future Microbiol 10(1):21\u201334. https:\/\/doi.org\/10.2217\/fmb.14.104","journal-title":"Future Microbiol"},{"issue":"2","key":"1_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/bfgp\/elv041","volume":"15","author":"JM Laurent","year":"2016","unstructured":"Laurent JM, Young JH, Kachroo AH, Marcotte EM (2016) Efforts to make and apply humanized yeast. Brief Funct Genomics 15(2):155\u2013163. https:\/\/doi.org\/10.1093\/bfgp\/elv041","journal-title":"Brief Funct Genomics"},{"issue":"1","key":"1_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0378-1119(92)90041-M","volume":"122","author":"P Leplatois","year":"1992","unstructured":"Leplatois P, Le Douarin B, Loison G (1992) High-level production of a peroxisomal enzyme: Aspergillus flavus uricase accumulates intracellularly and is active in Saccharomyces cerevisiae. Gene 122(1):139\u2013145. https:\/\/doi.org\/10.1016\/0378-1119(92)90041-M","journal-title":"Gene"},{"issue":"5","key":"1_CR60","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.3928\/19382359-20180424-01","volume":"47","author":"M Li","year":"2018","unstructured":"Li M (2018) Enzyme replacement therapy: a review and its role in treating lysosomal storage diseases. Pediatr Ann 47(5):e191\u2013e197. https:\/\/doi.org\/10.3928\/19382359-20180424-01","journal-title":"Pediatr Ann"},{"issue":"1","key":"1_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pep.2006.02.003","volume":"49","author":"J Li","year":"2006","unstructured":"Li J, Chen Z, Hou L, Fan H, Weng S, Ce X, Ren J, Li B, Chen W (2006) High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli. Protein Expr Purif 49(1):55\u201359. https:\/\/doi.org\/10.1016\/j.pep.2006.02.003","journal-title":"Protein Expr Purif"},{"issue":"5","key":"1_CR62","doi-asserted-by":"publisher","first-page":"e0177877","DOI":"10.1371\/journal.pone.0177877","volume":"12","author":"W Li","year":"2017","unstructured":"Li W, Xu S, Zhang B, Zhu Y, Hua Y, Kong X, Sun L, Hong J (2017) Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis. PLoS One 12(5):e0177877. https:\/\/doi.org\/10.1371\/journal.pone.0177877","journal-title":"PLoS One"},{"issue":"2","key":"1_CR63","first-page":"54","volume":"24","author":"J Lim","year":"2011","unstructured":"Lim J, Sinclair A, Shevitz J, Carter JB (2011) An economic comparison of three cell culture techniques: fed-batch, concentrated fed-batch, and concentrated perfusion. BioPharm Int 24(2):54\u201360","journal-title":"BioPharm Int"},{"issue":"6","key":"1_CR64","doi-asserted-by":"publisher","first-page":"e1005600","DOI":"10.1371\/journal.pcbi.1005600","volume":"13","author":"P L\u00f6ffler","year":"2017","unstructured":"L\u00f6ffler P, Schmitz S, Hupfeld E, Sterner R, Merkl R (2017) Rosetta:MSF: a modular framework for multi-state computational protein design. PLoS Comput Biol 13(6):e1005600. https:\/\/doi.org\/10.1371\/journal.pcbi.1005600","journal-title":"PLoS Comput Biol"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-319-50413-1_2","volume-title":"Directed enzyme evolution: advances and applications","author":"S Lutz","year":"2017","unstructured":"Lutz S, Williams E, Muthu P (2017) Engineering therapeutic enzymes. In: Alcalde M (ed) Directed enzyme evolution: advances and applications. Springer, Cham, pp 17\u201367. https:\/\/doi.org\/10.1007\/978-3-319-50413-1_2"},{"issue":"4","key":"1_CR66","first-page":"17","volume":"4","author":"P Mane","year":"2015","unstructured":"Mane P, Tale V (2015) Overview of microbial therapeutic enzymes. Int J Curr Microbiol Appl Sci 4(4):17\u201326","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"1_CR67","unstructured":"Market Research Engine (2018) Specialty enzymes market to touch US$ 5.5 Billion by 2022. Herald Keeper. http:\/\/heraldkeeper.com\/market\/specialty-enzymes-market-touch-us-5-5-billion-2022-2-96559.html. Accessed 17 Aug 2018"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"136419","DOI":"10.1155\/2014\/136419","volume":"2014","author":"M Merlin","year":"2014","unstructured":"Merlin M, Gecchele E, Capaldi S, Pezzotti M, Avesani L (2014) Comparative evaluation of recombinant protein production in different biofactories: the green perspective. Biomed Res Int 2014:136419\u2013136419. https:\/\/doi.org\/10.1155\/2014\/136419","journal-title":"Biomed Res Int"},{"issue":"1","key":"1_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2859-4-15","volume":"4","author":"I Mierau","year":"2005","unstructured":"Mierau I, Leij P, van Swam I, Blommestein B, Floris E, Mond J, Smid EJ (2005) Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microb Cell Factories 4(1):15. https:\/\/doi.org\/10.1186\/1475-2859-4-15","journal-title":"Microb Cell Factories"},{"issue":"3","key":"1_CR70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajps.2015.08.011","volume":"11","author":"P Mishra","year":"2016","unstructured":"Mishra P, Nayak B, Dey RK (2016) PEGylation in anti-cancer therapy: an overview. Asian J Pharm Sci 11(3):337\u2013348. https:\/\/doi.org\/10.1016\/j.ajps.2015.08.011","journal-title":"Asian J Pharm Sci"},{"issue":"9","key":"1_CR71","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri S, Burke PA, Langer R (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13(9):655\u2013672. https:\/\/doi.org\/10.1038\/nrd4363","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/wnan.73","volume":"2","author":"S Muro","year":"2010","unstructured":"Muro S (2010) New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(2):189\u2013204. https:\/\/doi.org\/10.1002\/wnan.73","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"2","key":"1_CR73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbapap.2012.11.002","volume":"1834","author":"M Nazari-Robati","year":"2013","unstructured":"Nazari-Robati M, Khajeh K, Aminian M, Mollania N, Golestani A (2013) Enhancement of thermal stability of chondroitinase ABC I by site-directed mutagenesis: an insight from Ramachandran plot. BBA-Proteins Proteomics 1834(2):479\u2013486. https:\/\/doi.org\/10.1016\/j.bbapap.2012.11.002","journal-title":"BBA-Proteins Proteomics"},{"key":"1_CR74","unstructured":"NDHHS NDoHaHS (2012) Therapeutic class overview pancreatic enzymes. https:\/\/www.medicaid.nv.gov\/Downloads\/provider\/Pancreatic%20Enzymes.pdf"},{"issue":"2","key":"1_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/187220808784619694","volume":"2","author":"R Nijland","year":"2008","unstructured":"Nijland R, Kuipers O (2008) Optimization of protein secretion by Bacillus subtilis. Recent Pat Biotechnol 2(2):79\u201387. https:\/\/doi.org\/10.2174\/187220808784619694","journal-title":"Recent Pat Biotechnol"},{"issue":"7","key":"1_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/protein\/gzu015","volume":"27","author":"B Noppen","year":"2014","unstructured":"Noppen B, Fonteyn L, Aerts F, De Vriese A, De Maeyer M, Le Floch F, Barbeaux P, Zwaal R, Vanhove M (2014) Autolytic degradation of ocriplasmin: a complex mechanism unraveled by mutational analysis. Protein Eng Des Sel 27(7):215\u2013223. https:\/\/doi.org\/10.1093\/protein\/gzu015","journal-title":"Protein Eng Des Sel"},{"issue":"8","key":"1_CR77","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5483\/BMBRep.2015.48.8.101","volume":"48","author":"D-B Oh","year":"2015","unstructured":"Oh D-B (2015) Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases. BMB Rep 48(8):438\u2013444. https:\/\/doi.org\/10.5483\/BMBRep.2015.48.8.101","journal-title":"BMB Rep"},{"key":"1_CR151","doi-asserted-by":"crossref","unstructured":"Oleck J, Kassam S, Goldman JD (2016) Diabetes Spectr 29(3):180\u2013184. https:\/\/doi.org\/10.2337\/diaspect.29.3.180","DOI":"10.2337\/diaspect.29.3.180"},{"issue":"46","key":"1_CR78","doi-asserted-by":"publisher","first-page":"16656","DOI":"10.1073\/pnas.0507332102","volume":"102","author":"Y Pan","year":"2005","unstructured":"Pan Y, Gao D, Yang W, Cho H, Yang G, Tai H-H, Zhan C-G (2005) Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci U S A 102(46):16656\u201316661. https:\/\/doi.org\/10.1073\/pnas.0507332102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR79","doi-asserted-by":"publisher","DOI":"10.1142\/8174","volume-title":"Discoveries in pharmacological sciences. Discoveries in pharmacological sciences","author":"PN Patil","year":"2012","unstructured":"Patil PN (2012) Discoveries in pharmacological sciences. Discoveries in pharmacological sciences. World Scientific Publishing Co., Singapore. https:\/\/doi.org\/10.1142\/8174"},{"issue":"1","key":"1_CR80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1939-8433-5-34","volume":"5","author":"T Patti","year":"2012","unstructured":"Patti T, Bembi B, Cristin P, Mazzarol F, Secco E, Pappalardo C, Musetti R, Martinuzzi M, Versolatto S, Cariati R, Dardis A, Marchetti S (2012) Endosperm-specific expression of human acid beta-glucosidase in a waxy rice. Rice 5(1):34. https:\/\/doi.org\/10.1186\/1939-8433-5-34","journal-title":"Rice"},{"key":"1_CR81","unstructured":"Persistence Market Research (2018) Therapeutic enzymes market: global industry trend analysis 2012 to 2017 and forecast 2017\u20132025. https:\/\/www.persistencemarketresearch.com\/market-research\/therapeutic-enzymes-market.asp. Accessed 14 Sept 2018"},{"key":"1_CR82","doi-asserted-by":"crossref","unstructured":"Petersen C (2015) History of health. Manuf Today :90\u201392","DOI":"10.7588\/worllitetoda.90.2.0092"},{"issue":"1","key":"1_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jbiotec.2003.10.038","volume":"109","author":"J-N Phue","year":"2004","unstructured":"Phue J-N, Shiloach J (2004) Transcription levels of key metabolic genes are the cause for different glucose utilization pathways in E. coli B (BL21) and E. coli K (JM109). J Biotechnol 109(1):21\u201330. https:\/\/doi.org\/10.1016\/j.jbiotec.2003.10.038","journal-title":"J Biotechnol"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cbpa.2015.08.009","volume":"28","author":"Y Qi","year":"2015","unstructured":"Qi Y, Chilkoti A (2015) Protein-polymer conjugation\u00a0\u2013 moving beyond PEGylation. Curr Opin Chem Biol 28:181\u2013193. https:\/\/doi.org\/10.1016\/j.cbpa.2015.08.009","journal-title":"Curr Opin Chem Biol"},{"issue":"12","key":"1_CR85","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1128\/AEM.64.12.4891-4896.1998","volume":"64","author":"J Qiu","year":"1998","unstructured":"Qiu J, Swartz JR, Georgiou G (1998) Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol 64(12):4891\u20134896","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"1_CR86","doi-asserted-by":"publisher","first-page":"e0197643","DOI":"10.1371\/journal.pone.0197643","volume":"13","author":"J Ramirez-Paz","year":"2018","unstructured":"Ramirez-Paz J, Saxena M, Delinois LJ, Joaqu\u00edn-Ovalle FM, Lin S, Chen Z, Rojas-Nieves VA, Griebenow K (2018) Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis. PLoS One 13(7):e0197643. https:\/\/doi.org\/10.1371\/journal.pone.0197643","journal-title":"PLoS One"},{"issue":"6","key":"1_CR87","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncprheum0214","volume":"2","author":"P Richette","year":"2006","unstructured":"Richette P, Bardin T (2006) Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol. Nat Clin Pract Rheumatol 2(6):338\u2013342.; quiz 343. https:\/\/doi.org\/10.1038\/ncprheum0214","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"1_CR88","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10529-009-9947-y","volume":"31","author":"JA Rodr\u00edguez-Mart\u00ednez","year":"2009","unstructured":"Rodr\u00edguez-Mart\u00ednez JA, Rivera-Rivera I, Sol\u00e1 RJ, Griebenow K (2009) Enzymatic activity and thermal stability of PEG-\u03b1-chymotrypsin conjugates. Biotechnol Lett 31(6):883\u2013887. https:\/\/doi.org\/10.1007\/s10529-009-9947-y","journal-title":"Biotechnol Lett"},{"issue":"3","key":"1_CR89","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/bp030070k","volume":"20","author":"ACA Roque","year":"2004","unstructured":"Roque ACA, Lowe CR, Taipa M\u00c2 (2004) Antibodies and genetically engineered related molecules: production and purification. Biotechnol Prog 20(3):639\u2013654. https:\/\/doi.org\/10.1021\/bp030070k","journal-title":"Biotechnol Prog"},{"issue":"1","key":"1_CR90","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chroma.2007.05.109","volume":"1160","author":"ACA Roque","year":"2007","unstructured":"Roque ACA, Silva CSO, Taipa M\u00c2 (2007) Affinity-based methodologies and ligands for antibody purification: advances and perspectives. J Chromatogr A 1160(1):44\u201355. https:\/\/doi.org\/10.1016\/j.chroma.2007.05.109","journal-title":"J Chromatogr A"},{"issue":"4","key":"1_CR91","first-page":"307","volume":"13","author":"M Roxas","year":"2008","unstructured":"Roxas M (2008) The role of enzyme supplementation in digestive disorders. Altern Med Rev 13(4):307\u2013314","journal-title":"Altern Med Rev"},{"issue":"1","key":"1_CR92","doi-asserted-by":"publisher","first-page":"5.25.21","DOI":"10.1002\/0471140864.ps0525s71","volume":"71","author":"BJ Ryan","year":"2013","unstructured":"Ryan BJ, Henehan GT (2013) Overview of approaches to preventing and avoiding proteolysis during expression and purification of proteins. Curr Protoc Protein Sci 71(1):5.25.21\u201325.25.27. https:\/\/doi.org\/10.1002\/0471140864.ps0525s71","journal-title":"Curr Protoc Protein Sci"},{"issue":"12","key":"1_CR93","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s10529-014-1621-3","volume":"36","author":"M Sabalza","year":"2014","unstructured":"Sabalza M, Christou P, Capell T (2014) Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Biotechnol Lett 36(12):2367\u20132379. https:\/\/doi.org\/10.1007\/s10529-014-1621-3","journal-title":"Biotechnol Lett"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4939-6637-0_2","volume-title":"Computational protein design","author":"I Samish","year":"2017","unstructured":"Samish I (2017) Achievements and challenges in computational protein design. In: Samish I (ed) Computational protein design. Springer, New York, pp 21\u201394. https:\/\/doi.org\/10.1007\/978-1-4939-6637-0_2"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.enzmictec.2017.06.004","volume":"105","author":"ME Shahaboddin","year":"2017","unstructured":"Shahaboddin ME, Khajeh K, Maleki M, Golestani A (2017) Improvement of activity and stability of Chondroitinase ABC I by introducing an aromatic cluster at the surface of protein. Enzym Microb Technol 105:38\u201344. https:\/\/doi.org\/10.1016\/j.enzmictec.2017.06.004","journal-title":"Enzym Microb Technol"},{"key":"1_CR152","unstructured":"Shan L, Bethune M, Khosla C, Gass J (2005) Therapeutic enzyme formulations and uses thereof WO\/2005\/107786"},{"key":"1_CR96","first-page":"1","volume-title":"Directory of therapeutic enzymes","author":"N Shanley","year":"2005","unstructured":"Shanley N, Walsh G (2005) Applied enzymology, an overview. In: McGrath BM, Walsh G (eds) Directory of therapeutic enzymes. CRC Press, Boca Raton, pp 1\u201316"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-394292-0.00003-5","volume-title":"Methods in enzymology","author":"O Sharabi","year":"2013","unstructured":"Sharabi O, Erijman A, Shifman JM (2013) Chapter 3: Computational methods for controlling binding specificity. In: Keating AE (ed) Methods in enzymology, vol 523. Academic, Burlington, pp 41\u201359. https:\/\/doi.org\/10.1016\/B978-0-12-394292-0.00003-5"},{"issue":"3","key":"1_CR98","first-page":"214","volume":"20","author":"GR Sharifi-Sirchi","year":"2016","unstructured":"Sharifi-Sirchi GR, Jalali-Javaran M (2016) Selecting appropriate hosts for recombinant proteins production: review article. HMJ 20(3):214\u2013222","journal-title":"HMJ"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2017.09.009","volume":"118","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Bagshawe KD (2017) Antibody directed enzyme prodrug therapy (ADEPT): trials and tribulations. Adv Drug Deliv Rev 118:2\u20137. https:\/\/doi.org\/10.1016\/j.addr.2017.09.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1_CR100","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s13205-016-0485-8","volume":"6","author":"R Singh","year":"2016","unstructured":"Singh R, Kumar M, Mittal A, Mehta PK (2016) Microbial enzymes: industrial progress in 21st century. 3 Biotech 6(2):174\u2013174. https:\/\/doi.org\/10.1007\/s13205-016-0485-8","journal-title":"3 Biotech"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2164(08)70087-X","volume-title":"Advances in applied microbiology","author":"IW Sizer","year":"1972","unstructured":"Sizer IW (1972) Medical applications of microbial enzymes. In: Perlman D (ed) Advances in applied microbiology, vol 15. Academic, New York, pp 1\u201311. https:\/\/doi.org\/10.1016\/S0065-2164(08)70087-X"},{"issue":"5","key":"1_CR102","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/btpr.634","volume":"27","author":"JP Smelko","year":"2011","unstructured":"Smelko JP, Wiltberger KR, Hickman EF, Morris BJ, Blackburn TJ, Ryll T (2011) Performance of high intensity fed-batch mammalian cell cultures in disposable bioreactor systems. Biotechnol Prog 27(5):1358\u20131364. https:\/\/doi.org\/10.1002\/btpr.634","journal-title":"Biotechnol Prog"},{"issue":"1","key":"1_CR103","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1467-7652.2006.00216.x","volume":"5","author":"SJ Streatfield","year":"2007","unstructured":"Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5(1):2\u201315. https:\/\/doi.org\/10.1111\/j.1467-7652.2006.00216.x","journal-title":"Plant Biotechnol J"},{"issue":"7","key":"1_CR104","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1389200216666141208151524","volume":"15","author":"PH Tobin","year":"2014","unstructured":"Tobin PH, Richards DH, Callender RA, Wilson CJ (2014) Protein engineering: a new frontier for biological therapeutics. Curr Drug Metab 15(7):743\u2013756","journal-title":"Curr Drug Metab"},{"issue":"3","key":"1_CR105","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cben.201600002","volume":"3","author":"NK Tripathi","year":"2016","unstructured":"Tripathi NK (2016) Production and purification of recombinant proteins from Escherichia coli. ChemBioEng Rev 3(3):116\u2013133. https:\/\/doi.org\/10.1002\/cben.201600002","journal-title":"ChemBioEng Rev"},{"issue":"2","key":"1_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.14429\/dsj.59.1501","volume":"59","author":"N Tripathi","year":"2009","unstructured":"Tripathi N, Kannusamy S, Jana A, Rao PVL (2009) High yield production of heterologous proteins with Escherichia coli. Def Sci J 59(2):137\u2013146. https:\/\/doi.org\/10.14429\/dsj.59.1501","journal-title":"Def Sci J"},{"issue":"1","key":"1_CR107","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/15422119.2016.1184167","volume":"46","author":"LL Tundisi","year":"2017","unstructured":"Tundisi LL, Co\u00ealho DF, Zanchetta B, Moriel P, Pessoa A, Tambourgi EB, Silveira E, Mazzola PG (2017) L-Asparaginase purification. Sep Purif Rev 46(1):35\u201343. https:\/\/doi.org\/10.1080\/15422119.2016.1184167","journal-title":"Sep Purif Rev"},{"key":"1_CR108","unstructured":"Varga I, Bobalova M, Michalkova E, Jakubcova M (2011) Method of polymyxin B recovery from fermentation broth. USA Patent US7951913B2, 2011-05-31"},{"issue":"4","key":"1_CR109","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0958-1669(03)00092-2","volume":"14","author":"M Vellard","year":"2003","unstructured":"Vellard M (2003) The enzyme as drug: application of enzymes as pharmaceuticals. Curr Opin Biotechnol 14(4):444\u2013450. https:\/\/doi.org\/10.1016\/S0958-1669(03)00092-2","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"1_CR110","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/07388550601173926","volume":"27","author":"N Verma","year":"2007","unstructured":"Verma N, Kumar K, Kaur G, Anand S (2007) L-asparaginase: a promising chemotherapeutic agent. Crit Rev Biotechnol 27(1):45\u201362. https:\/\/doi.org\/10.1080\/07388550601173926","journal-title":"Crit Rev Biotechnol"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.enzmictec.2013.12.012","volume":"56","author":"J Vidya","year":"2014","unstructured":"Vidya J, Ushasree MV, Pandey A (2014) Effect of surface charge alteration on stability of L-asparaginase II from Escherichia sp. Enzym Microb Technol 56:15\u201319. https:\/\/doi.org\/10.1016\/j.enzmictec.2013.12.012","journal-title":"Enzym Microb Technol"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/B978-0-444-63662-1.00012-9","volume-title":"Current developments in biotechnology and bioengineering","author":"J Vidya","year":"2017","unstructured":"Vidya J, Sajitha S, Ushasree MV, Binod P, Pandey A (2017) 12\u00a0\u2013 Therapeutic enzymes: l-Asparaginases. In: Pandey A, Negi S, Soccol CR (eds) Current developments in biotechnology and bioengineering. Elsevier, Amsterdam, pp 249\u2013265. https:\/\/doi.org\/10.1016\/B978-0-444-63662-1.00012-9"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nbt.3040","volume":"32","author":"G Walsh","year":"2014","unstructured":"Walsh G (2014) Biopharmaceutical benchmarks 2014. Nat Biotechnol 32:992. https:\/\/doi.org\/10.1038\/nbt.3040. https:\/\/www.nature.com\/articles\/nbt.3040#supplementary-information","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1_CR114","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/bit.20816","volume":"94","author":"A Wang","year":"2006","unstructured":"Wang A, Lewus R, Rathore AS (2006) Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth. Biotechnol Bioeng 94(1):91\u2013104. https:\/\/doi.org\/10.1002\/bit.20816","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"1_CR115","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pep.2011.08.005","volume":"80","author":"DS Waugh","year":"2011","unstructured":"Waugh DS (2011) An overview of enzymatic reagents for the removal of affinity tags. Protein Expr Purif 80(2):283\u2013293. https:\/\/doi.org\/10.1016\/j.pep.2011.08.005","journal-title":"Protein Expr Purif"},{"issue":"1","key":"1_CR116","doi-asserted-by":"publisher","first-page":"1600105","DOI":"10.1002\/biot.201600105","volume":"12","author":"E Wells","year":"2017","unstructured":"Wells E, Robinson AS (2017) Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement. Biotechnol J 12(1):1600105. https:\/\/doi.org\/10.1002\/biot.201600105","journal-title":"Biotechnol J"},{"issue":"1","key":"1_CR117","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbamcr.2004.02.011","volume":"1694","author":"L Westers","year":"2004","unstructured":"Westers L, Westers H, Quax WJ (2004) Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. BBA-Mol Cell Res 1694(1):299\u2013310. https:\/\/doi.org\/10.1016\/j.bbamcr.2004.02.011","journal-title":"BBA-Mol Cell Res"},{"issue":"13","key":"1_CR118","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1111\/febs.12324","volume":"280","author":"HJ Wijma","year":"2013","unstructured":"Wijma HJ, Janssen DB (2013) Computational design gains momentum in enzyme catalysis engineering. FEBS J 280(13):2948\u20132960. https:\/\/doi.org\/10.1111\/febs.12324","journal-title":"FEBS J"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrmicro1087","volume":"3","author":"S Wildt","year":"2005","unstructured":"Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 3:119\u2013128. https:\/\/doi.org\/10.1038\/nrmicro1087","journal-title":"Nat Rev Microbiol"},{"key":"1_CR120","doi-asserted-by":"publisher","unstructured":"Willson RC, Ladisch MR (1990) Large-scale protein purification. In: Protein purification. vol 427. ACS Symposium Series, vol 427. American Chemical Society, pp 1\u201313. https:\/\/doi.org\/10.1021\/bk-1990-0427.ch001","DOI":"10.1021\/bk-1990-0427.ch001"},{"issue":"16","key":"1_CR121","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1021\/ie503060a","volume":"54","author":"H Xiao","year":"2015","unstructured":"Xiao H, Bao Z, Zhao H (2015) High throughput screening and selection methods for directed enzyme evolution. Ind Eng Chem Res 54(16):4011\u20134020. https:\/\/doi.org\/10.1021\/ie503060a","journal-title":"Ind Eng Chem Res"},{"issue":"2","key":"1_CR122","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1124\/mol.110.068494","volume":"79","author":"L Xue","year":"2011","unstructured":"Xue L, Ko M-C, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai H-H, Zhan C-G (2011) Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Mol Pharmacol 79(2):290\u2013297. https:\/\/doi.org\/10.1124\/mol.110.068494","journal-title":"Mol Pharmacol"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-803725-6.00006-6","volume-title":"Biotechnology of microbial enzymes","author":"H Yang","year":"2017","unstructured":"Yang H, Li J, Du G, Liu L (2017) Chapter 6: Microbial production and molecular engineering of industrial enzymes: challenges and strategies. In: Brahmachari G (ed) Biotechnology of microbial enzymes. Academic, Amsterdam, pp 151\u2013165. https:\/\/doi.org\/10.1016\/B978-0-12-803725-6.00006-6"},{"issue":"7","key":"1_CR124","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/1389201018666170808150742","volume":"18","author":"M Yari","year":"2017","unstructured":"Yari M, Ghoshoon MB, Vakili B, Ghasemi Y (2017) Therapeutic enzymes: applications and approaches to pharmacological improvement. Curr Pharm Biotechnol 18(7):531\u2013540. https:\/\/doi.org\/10.2174\/1389201018666170808150742","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1_CR125","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.canlet.2014.11.042","volume":"357","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liu M, Jamil S, Han R, Xu G, Ni Y (2015) PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida. Cancer Lett 357(1):346\u2013354. https:\/\/doi.org\/10.1016\/j.canlet.2014.11.042","journal-title":"Cancer Lett"},{"issue":"1","key":"1_CR126","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/prep.2000.1230","volume":"19","author":"K-W Zhao","year":"2000","unstructured":"Zhao K-W, Neufeld EF (2000) Purification and characterization of recombinant human \u03b1-N-acetylglucosaminidase secreted by Chinese hamster ovary cells. Protein Expr Purif 19(1):202\u2013211. https:\/\/doi.org\/10.1006\/prep.2000.1230","journal-title":"Protein Expr Purif"},{"issue":"9","key":"1_CR127","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10822-007-9144-9","volume":"22","author":"F Zheng","year":"2008","unstructured":"Zheng F, Zhan C-G (2008) Rational design of an enzyme mutant for anti-cocaine therapeutics. J Comput Aided Mol Des 22(9):661\u2013671. https:\/\/doi.org\/10.1007\/s10822-007-9144-9","journal-title":"J Comput Aided Mol Des"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/978-0-387-27843-8_32","volume-title":"Kent and Riegel\u2019s handbook of industrial chemistry and biotechnology","author":"MM Zhu","year":"2007","unstructured":"Zhu MM, Mollet M, Hubert RS (2007) Industrial production of therapeutic proteins: cell lines, cell culture, and purification. In: Kent JA (ed) Kent and Riegel\u2019s handbook of industrial chemistry and biotechnology. Springer, Boston, pp 1421\u20131448. https:\/\/doi.org\/10.1007\/978-0-387-27843-8_32"},{"issue":"5","key":"1_CR129","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/cbic.200900717","volume":"11","author":"L Zhu","year":"2010","unstructured":"Zhu L, Tee KL, Roccatano D, Sonmez B, Ni Y, Sun Z-H, Schwaneberg U (2010) Directed evolution of an antitumor drug (arginine deiminase PpADI) for increased activity at physiological pH. Chembiochem 11(5):691\u2013697. https:\/\/doi.org\/10.1002\/cbic.200900717","journal-title":"Chembiochem"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/978-3-319-52287-6_29","volume-title":"Handbook of industrial chemistry and biotechnology","author":"MM Zhu","year":"2017","unstructured":"Zhu MM, Mollet M, Hubert RS, Kyung YS, Zhang GG (2017) Industrial production of therapeutic proteins: cell lines, cell culture, and purification. In: Kent JA, Bommaraju TV, Barnicki SD (eds) Handbook of industrial chemistry and biotechnology. Springer, Cham, pp 1639\u20131669. https:\/\/doi.org\/10.1007\/978-3-319-52287-6_29"},{"issue":"22","key":"1_CR131","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","volume":"118","author":"A Zimran","year":"2011","unstructured":"Zimran A, Brill-Almon E, Chertkoff R, Petakov M, Blanco-Favela F, Terreros Mu\u00f1oz E, Solorio-Meza SE, Amato D, Duran G, Giona F, Heitner R, Rosenbaum H, Giraldo P, Mehta A, Park G, Phillips M, Elstein D, Altarescu G, Szleifer M, Hashmueli S, Aviezer D (2011) Pivotal trial with plant-cell\u2013expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118(22):5767\u20135773. https:\/\/doi.org\/10.1182\/blood-2011-07-366955","journal-title":"Blood"}],"container-title":["Advances in Experimental Medicine and Biology","Therapeutic Enzymes: Function and Clinical Implications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7709-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T18:25:17Z","timestamp":1647973517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-7709-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811377082","9789811377099"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7709-9_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"4 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}